Pharmacokinetics of Olverembatinib in Participants With Hepatic Impairment

NCT07282093 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetic
Olverembatinib

Interventions

DRUG: Olverembatinib 20mg

Sponsor

Ascentage Pharma Group Inc.

Collaborators

[object Object]